Bristol-Myers Squibb Company (BMY)

NYSE: BMY · Real-Time Price · USD

59.37

-0.34 (-0.57%)

At close: Mar 18, 2026, 4:00 PM EDT

59.15

-0.22 (-0.37%)

Pre-market: Mar 19, 2026, 4:41 AM EDT

BMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	48,194	48,300	45,006	46,159	46,385
Revenue Growth (YoY)	-0.22%	7.32%	-2.50%	-0.49%	9.10%
Cost of Revenue	13,936	13,968	10,693	10,137	9,940
Gross Profit	34,258	34,332	34,313	36,022	36,445
Selling, General & Admin	7,267	8,414	7,772	7,814	7,690
Depreciation & Amortization Expenses	3,317	8,872	9,047	9,595	10,023
Research & Development	13,672	24,532	10,212	10,324	11,354
Total Operating Expenses	24,256	41,818	27,031	27,733	29,067
Operating Income	10,002	-7,486	7,282	8,289	7,378
Other Non-Operating Income (Expense)	-674	-893	1,158	-576	720
Total Non-Operating Income (Expense)	-674	-893	1,158	-576	720
Pretax Income	9,328	-8,379	8,440	7,713	8,098
Provision for Income Taxes	2,272	554	400	1,368	1,084
Net Income	7,054	-8,948	8,025	6,327	6,994
Minority Interest in Earnings	2	15	15	18	20
Net Income to Common	7,054	-8,948	8,025	6,327	6,994
Net Income Growth	-	-	26.84%	-9.54%	-
Shares Outstanding (Basic)	2,034	2,027	2,069	2,130	2,221
Shares Outstanding (Diluted)	2,039	2,027	2,078	2,146	2,245
Shares Change (YoY)	0.59%	-2.45%	-3.17%	-4.41%	-0.58%
EPS (Basic)	3.47	-4.41	3.88	2.97	3.15
EPS (Diluted)	3.46	-4.41	3.86	2.95	3.12
EPS Growth	-	-	30.85%	-5.45%	-
Free Cash Flow	12,845	13,942	12,651	11,948	15,234
Free Cash Flow Growth	-7.87%	10.21%	5.88%	-21.57%	14.55%
Free Cash Flow Per Share	6.30	6.88	6.09	5.57	6.79
Dividends Per Share	2.490	2.420	2.310	2.190	2.010
Dividend Growth	2.89%	4.76%	5.48%	8.96%	9.24%
Gross Margin	71.08%	71.08%	76.24%	78.04%	78.57%
Operating Margin	20.75%	-15.50%	16.18%	17.96%	15.91%
Profit Margin	14.64%	-18.49%	17.86%	13.75%	15.12%
FCF Margin	26.65%	28.87%	28.11%	25.88%	32.84%
EBITDA	14,013	2,114	17,042	18,565	18,064
EBITDA Margin	29.08%	4.38%	37.87%	40.22%	38.94%
EBIT	10,002	-7,486	7,282	8,289	7,378
EBIT Margin	20.75%	-15.50%	16.18%	17.96%	15.91%
Effective Tax Rate	24.36%	-6.61%	4.74%	17.74%	13.39%

Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q